|
GUF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64923630308067E-12 |
| Normal-vs-Stage2 |
1.33530000001603E-06 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
2.858800E-01 |
| Stage1-vs-Stage3 |
8.218400E-03 |
| Stage1-vs-Stage4 |
2.118400E-03 |
| Stage2-vs-Stage3 |
2.078200E-02 |
| Stage2-vs-Stage4 |
8.458100E-03 |
| Stage3-vs-Stage4 |
5.763600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6242562850266E-12 |
| Normal-vs-AfricanAmerican |
1.24540000534523E-09 |
| Normal-vs-Asian |
5.720300E-03 |
| Caucasian-vs-AfricanAmerican |
1.664210E-01 |
| Caucasian-vs-Asian |
5.042000E-01 |
| AfricanAmerican-vs-Asian |
9.023600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
4.29656310529936E-14 |
| Male-vs-Female |
7.704100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.96979999481195E-08 |
| Normal-vs-Age(41-60Yrs) |
1.6242562850266E-12 |
| Normal-vs-Age(61-80Yrs) |
1.6242562850266E-12 |
| Normal-vs-Age(81-100Yrs) |
2.78349998605876E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.853200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.321400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.732000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.972000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.873200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.359200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.38220000024081E-07 |
| Normal-vs-Grade 2 |
2.22044604925031E-16 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
4.031600E-01 |
| Grade 1-vs-Grade 3 |
4.636100E-02 |
| Grade 1-vs-Grade 4 |
5.176500E-02 |
| Grade 2-vs-Grade 3 |
3.301800E-02 |
| Grade 2-vs-Grade 4 |
1.130060E-02 |
| Grade 3-vs-Grade 4 |
2.526400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.62458935193399E-12 |
| ccA subtype-vs-ccB subtype |
1.752210E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62458935193399E-12 |
| Normal-vs-N1 |
4.59919999973302E-07 |
| N0-vs-N1 |
2.952600E-01 |
|
|
